期刊文献+

麻疹、流行性腮腺炎二联活疫苗中量试制 被引量:4

Experimental Preparation of Live Measles-Mumps Combined Vaccine
暂未订购
导出
摘要 用麻疹沪191株和流腮S79株中量试制麻疹、流腮二联活疫苗,对疫苗原液的配制比例、二联疫苗与单价疫苗的病毒滴度和稳定性进行比较。结果提高流腮疫苗原液的比例可获得较好效果;9批麻腮二联疫苗全部达到现行单价疫苗规程要求;二联疫苗在4~8℃保存18个月的稳定性与单价疫苗基本一致。 A live measles-mumps combined vaccine was prepared with strain Hu191(measles) and S79 (mumps). The proportion of stock solution of measles and mumps vaccineswere studied, and the titer and stability of the combined vaccine were compared with those ofmonovalent measles and mumps vaccines. The result showed that the combined vaccine wasmore effective after the proportion of mumps vaccine stock solution was improved. All thequalities of 9 lots of measles-mumps combined vaccine reached the current requirements formonovalent vaccine. After being stored at 4~8℃ for 18 months, the stability of the vaccinewas basically consistent with that of monovalent vaccine under the same conditions.
出处 《中国生物制品学杂志》 CAS CSCD 1998年第4期211-214,共4页 Chinese Journal of Biologicals
关键词 麻疹 二联活疫苗 流行性腮腺炎 稳定性 Live measles-mumps combined vaccine Stability
  • 相关文献

参考文献1

二级参考文献1

  • 1李淑云,高静,魏静,唐慧英.冻干麻疹活疫苗病毒滴定条件的选择[J]中国生物制品学杂志,1995(04).

同被引文献14

  • 1中国生物制品标准化委员会.中国生物制品规程(2000年版)[M].北京:化学工业出版社,.148.
  • 2.SARS病毒灭活疫苗临床前研究技术要点[s].国食药监注[2003]128号.[S].国家食品药品监督管理局,2003年7月1日..
  • 3中国生物制品标准化委员会编.中国生物制品规程2000年版[s].北京:化学工业出版社,.9-10.
  • 4国家药典委员会编.中华人民共和国药典,第二部[s].北京:化学工业出版社,2000年版.附录197.
  • 5卫生部生物制品标准化委员会编.中国生物制品规程(一部)[S].1995年版.北京:中国人口出版社,1995,126-132.
  • 6Rosemorie berge, Max Just, Reinbard Gluick. Interference between strains in live virus vaccines: combined vaccination with measles,mumps and rubella vaccine. Journal of Biological Standardization [S], 1988,16(4) :269-273.
  • 7Andre FE, Stanbury WJ, Teuwen DE, Conventional and New Generation Combined Vaccines//Kurstak E. Modern Vaeeinology. New York: Plenum Publishing Corporation, 1994 :41-54.
  • 8Wharton M, Cochi SL, Williams WW, et al. Measles, mumps and rubella vaccines. Infect Dis Clin North Am,1990,4(1):47- 73.
  • 9Schwarzer S,Reibel S,Lang AB,et al. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccine. Vaccine, 1998,16 (2/3) : 298- 304.
  • 10WHO expert committee on biological standardization;WHO Technical Report Series, 1994 (840) : 152-158.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部